Clinical trial
Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors
NCT00072436 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00072436 |
|---|---|
| Title | Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors |
| Official title | A Phase I Trial of Gemcitabine Followed by a Short Infusion of Flavopiridol in Patients With Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | gemcitabine hydrochloride, alvocidib, pharmacological study |
| Enrollment | 58 |
| Start date | Sep 1, 2003 |
| Primary completion | Mar 1, 2009 |
| First posted | Nov 6, 2003 |
| Last update posted | Jul 2, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: